<DOC>
	<DOCNO>NCT00501891</DOCNO>
	<brief_summary>This phase II study combination Avastin metronomic temozolomide recurrent malignant glioma patient . The primary objective determine efficacy Avastin ( bevacizumab ) metronomic temozolomide malignant glioma patient . The secondary objective determine safety Avastin , 10 mg/kg every week , combination metronomic temozolomide term progression-free survival .</brief_summary>
	<brief_title>Bevacizumab Combination With Metronomic Temozolomide Recurrent Malignant Glioma</brief_title>
	<detailed_description>This phase II trial combination Avastin metronomic temozolomide recurrent WHO grade IV malignant glioma patient . Patients receive 12 cycle Avastin temozolomide cycle continuous 28 day . Patients receive daily temozolomide dose 50mg/m2 receive Avastin every week dose 10mg/kg . Patients required baseline MRI within 2 week start treatment repeat MRI every 8 week . A total 32 patient enrolled Duke . Patients recurrent malignant glioma poor prognosis , new therapy need . Given activity metronomic temozolomide safety activity Avastin malignant glioma , reasonable study combination recurrent malignant glioma patient .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Patients must histologically confirm diagnosis WHO grade IV primary malignant glioma Karnofsy Performance Status ( KPS ) &gt; /= 60 % Evidence measurable primary CNS neoplasm contrastenhanced MRI . An interval least 4 week prior surgical resection 1 week biopsy enrollment protocol An interval least 4 week end prior radiotherapy one week end cycle chemotherapy enrollment protocol . No evidence CNS hemorrhage baseline MRI CT scan Life expectancy &lt; 8 week Pregnancy breast feeding Progression metronomic temozolomide , define tumor progression take daily temozolomide progression within 4 week stop metronomic temozolomide Inadequately control hypertension ( define systolic blood pressure &gt; 150 and/or diastolic blood pressure &gt; 100 mmHg antihypertensive medication )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Glioblastoma Multiforme</keyword>
	<keyword>Brain Central Nervous System Tumors</keyword>
	<keyword>Recurrent Malignant Glioma</keyword>
	<keyword>Recurrent Glioblastoma Multiforme</keyword>
	<keyword>Avastin</keyword>
	<keyword>Bevacizumab</keyword>
	<keyword>Temodar</keyword>
	<keyword>Temozolomide</keyword>
</DOC>